nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—migraine—Prednisone—psoriatic arthritis	0.717	1	CpDpCtD
Dihydroergotamine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0344	0.167	CbGbCtD
Dihydroergotamine—ABCB1—Betamethasone—psoriatic arthritis	0.0224	0.108	CbGbCtD
Dihydroergotamine—ABCB1—Prednisolone—psoriatic arthritis	0.0221	0.107	CbGbCtD
Dihydroergotamine—ABCB1—Prednisone—psoriatic arthritis	0.0209	0.101	CbGbCtD
Dihydroergotamine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0206	0.0999	CbGbCtD
Dihydroergotamine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0156	0.0757	CbGbCtD
Dihydroergotamine—CYP3A4—Betamethasone—psoriatic arthritis	0.0134	0.065	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisolone—psoriatic arthritis	0.0132	0.0641	CbGbCtD
Dihydroergotamine—ABCB1—Dexamethasone—psoriatic arthritis	0.013	0.0631	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisone—psoriatic arthritis	0.0125	0.0605	CbGbCtD
Dihydroergotamine—ABCB1—Methotrexate—psoriatic arthritis	0.0105	0.0507	CbGbCtD
Dihydroergotamine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0078	0.0378	CbGbCtD
Dihydroergotamine—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000269	0.00353	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000268	0.00352	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000268	0.00351	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.000266	0.00349	CcSEcCtD
Dihydroergotamine—Epistaxis—Triamcinolone—psoriatic arthritis	0.000258	0.00339	CcSEcCtD
Dihydroergotamine—Visual impairment—Prednisolone—psoriatic arthritis	0.000257	0.00338	CcSEcCtD
Dihydroergotamine—Muscular weakness—Prednisone—psoriatic arthritis	0.000247	0.00325	CcSEcCtD
Dihydroergotamine—Rhinitis—Triamcinolone—psoriatic arthritis	0.000246	0.00323	CcSEcCtD
Dihydroergotamine—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000246	0.00322	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000245	0.00321	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000245	0.00321	CcSEcCtD
Dihydroergotamine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000244	0.0032	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000243	0.00319	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000243	0.00319	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.000241	0.00317	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Betamethasone—psoriatic arthritis	0.000241	0.00317	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000239	0.00314	CcSEcCtD
Dihydroergotamine—Sweating increased—Prednisone—psoriatic arthritis	0.000236	0.0031	CcSEcCtD
Dihydroergotamine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000236	0.0031	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000216	0.00283	CcSEcCtD
Dihydroergotamine—Visual impairment—Dexamethasone—psoriatic arthritis	0.000215	0.00282	CcSEcCtD
Dihydroergotamine—Visual impairment—Betamethasone—psoriatic arthritis	0.000215	0.00282	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000213	0.0028	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Prednisone—psoriatic arthritis	0.000212	0.00278	CcSEcCtD
Dihydroergotamine—Malaise—Prednisolone—psoriatic arthritis	0.00021	0.00275	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisolone—psoriatic arthritis	0.000209	0.00274	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisolone—psoriatic arthritis	0.000201	0.00263	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000198	0.0026	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000198	0.0026	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisolone—psoriatic arthritis	0.000196	0.00257	CcSEcCtD
Dihydroergotamine—Malaise—Triamcinolone—psoriatic arthritis	0.000193	0.00253	CcSEcCtD
Dihydroergotamine—Malaise—Methylprednisolone—psoriatic arthritis	0.000192	0.00252	CcSEcCtD
Dihydroergotamine—Vertigo—Triamcinolone—psoriatic arthritis	0.000192	0.00252	CcSEcCtD
Dihydroergotamine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000192	0.00251	CcSEcCtD
Dihydroergotamine—Oedema—Prednisolone—psoriatic arthritis	0.00019	0.00249	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000188	0.00247	CcSEcCtD
Dihydroergotamine—Shock—Prednisolone—psoriatic arthritis	0.000187	0.00245	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisolone—psoriatic arthritis	0.000185	0.00243	CcSEcCtD
Dihydroergotamine—Hypertension—Triamcinolone—psoriatic arthritis	0.000185	0.00242	CcSEcCtD
Dihydroergotamine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000184	0.00242	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000183	0.00241	CcSEcCtD
Dihydroergotamine—Myalgia—Triamcinolone—psoriatic arthritis	0.000182	0.00239	CcSEcCtD
Dihydroergotamine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000182	0.00238	CcSEcCtD
Dihydroergotamine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000182	0.00238	CcSEcCtD
Dihydroergotamine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000181	0.00237	CcSEcCtD
Dihydroergotamine—Flushing—Prednisone—psoriatic arthritis	0.00018	0.00236	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00018	0.00236	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00018	0.00236	CcSEcCtD
Dihydroergotamine—Discomfort—Triamcinolone—psoriatic arthritis	0.00018	0.00236	CcSEcCtD
Dihydroergotamine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000179	0.00235	CcSEcCtD
Dihydroergotamine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000178	0.00234	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000176	0.0023	CcSEcCtD
Dihydroergotamine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000176	0.0023	CcSEcCtD
Dihydroergotamine—Malaise—Dexamethasone—psoriatic arthritis	0.000175	0.0023	CcSEcCtD
Dihydroergotamine—Malaise—Betamethasone—psoriatic arthritis	0.000175	0.0023	CcSEcCtD
Dihydroergotamine—Oedema—Triamcinolone—psoriatic arthritis	0.000174	0.00229	CcSEcCtD
Dihydroergotamine—Vertigo—Dexamethasone—psoriatic arthritis	0.000174	0.00229	CcSEcCtD
Dihydroergotamine—Vertigo—Betamethasone—psoriatic arthritis	0.000174	0.00229	CcSEcCtD
Dihydroergotamine—Shock—Triamcinolone—psoriatic arthritis	0.000172	0.00225	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisolone—psoriatic arthritis	0.000172	0.00225	CcSEcCtD
Dihydroergotamine—Shock—Methylprednisolone—psoriatic arthritis	0.000171	0.00225	CcSEcCtD
Dihydroergotamine—Epistaxis—Methotrexate—psoriatic arthritis	0.00017	0.00224	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00017	0.00224	CcSEcCtD
Dihydroergotamine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00017	0.00223	CcSEcCtD
Dihydroergotamine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00017	0.00223	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000169	0.00221	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000168	0.00221	CcSEcCtD
Dihydroergotamine—Hypertension—Dexamethasone—psoriatic arthritis	0.000167	0.0022	CcSEcCtD
Dihydroergotamine—Hypertension—Betamethasone—psoriatic arthritis	0.000167	0.0022	CcSEcCtD
Dihydroergotamine—Myalgia—Betamethasone—psoriatic arthritis	0.000165	0.00217	CcSEcCtD
Dihydroergotamine—Myalgia—Dexamethasone—psoriatic arthritis	0.000165	0.00217	CcSEcCtD
Dihydroergotamine—Anxiety—Betamethasone—psoriatic arthritis	0.000165	0.00216	CcSEcCtD
Dihydroergotamine—Anxiety—Dexamethasone—psoriatic arthritis	0.000165	0.00216	CcSEcCtD
Dihydroergotamine—Discomfort—Dexamethasone—psoriatic arthritis	0.000163	0.00214	CcSEcCtD
Dihydroergotamine—Discomfort—Betamethasone—psoriatic arthritis	0.000163	0.00214	CcSEcCtD
Dihydroergotamine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000163	0.00213	CcSEcCtD
Dihydroergotamine—Pain—Prednisolone—psoriatic arthritis	0.000162	0.00213	CcSEcCtD
Dihydroergotamine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000161	0.00211	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000159	0.00209	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000159	0.00208	CcSEcCtD
Dihydroergotamine—Oedema—Dexamethasone—psoriatic arthritis	0.000158	0.00208	CcSEcCtD
Dihydroergotamine—Oedema—Betamethasone—psoriatic arthritis	0.000158	0.00208	CcSEcCtD
Dihydroergotamine—Insomnia—Triamcinolone—psoriatic arthritis	0.000158	0.00207	CcSEcCtD
Dihydroergotamine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000157	0.00207	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000157	0.00206	CcSEcCtD
Dihydroergotamine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000157	0.00206	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000156	0.00205	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000156	0.00205	CcSEcCtD
Dihydroergotamine—Visual impairment—Methotrexate—psoriatic arthritis	0.000156	0.00205	CcSEcCtD
Dihydroergotamine—Shock—Dexamethasone—psoriatic arthritis	0.000156	0.00204	CcSEcCtD
Dihydroergotamine—Shock—Betamethasone—psoriatic arthritis	0.000156	0.00204	CcSEcCtD
Dihydroergotamine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000156	0.00204	CcSEcCtD
Dihydroergotamine—Agitation—Prednisone—psoriatic arthritis	0.000155	0.00204	CcSEcCtD
Dihydroergotamine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000154	0.00203	CcSEcCtD
Dihydroergotamine—Tachycardia—Betamethasone—psoriatic arthritis	0.000154	0.00203	CcSEcCtD
Dihydroergotamine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000154	0.00202	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000153	0.00201	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000153	0.00201	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000153	0.00201	CcSEcCtD
Dihydroergotamine—Malaise—Prednisone—psoriatic arthritis	0.000152	0.002	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisone—psoriatic arthritis	0.000152	0.00199	CcSEcCtD
Dihydroergotamine—Tinnitus—Methotrexate—psoriatic arthritis	0.000151	0.00198	CcSEcCtD
Dihydroergotamine—Anorexia—Dexamethasone—psoriatic arthritis	0.000151	0.00198	CcSEcCtD
Dihydroergotamine—Anorexia—Betamethasone—psoriatic arthritis	0.000151	0.00198	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisolone—psoriatic arthritis	0.000151	0.00198	CcSEcCtD
Dihydroergotamine—Fatigue—Triamcinolone—psoriatic arthritis	0.00015	0.00197	CcSEcCtD
Dihydroergotamine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00015	0.00197	CcSEcCtD
Dihydroergotamine—Pain—Triamcinolone—psoriatic arthritis	0.000149	0.00196	CcSEcCtD
Dihydroergotamine—Hypotension—Dexamethasone—psoriatic arthritis	0.000148	0.00194	CcSEcCtD
Dihydroergotamine—Hypotension—Betamethasone—psoriatic arthritis	0.000148	0.00194	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisone—psoriatic arthritis	0.000146	0.00191	CcSEcCtD
Dihydroergotamine—Chills—Methotrexate—psoriatic arthritis	0.000146	0.00191	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000144	0.00189	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000144	0.00189	CcSEcCtD
Dihydroergotamine—Arthralgia—Prednisone—psoriatic arthritis	0.000144	0.00189	CcSEcCtD
Dihydroergotamine—Myalgia—Prednisone—psoriatic arthritis	0.000144	0.00189	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000144	0.00189	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000143	0.00188	CcSEcCtD
Dihydroergotamine—Anxiety—Prednisone—psoriatic arthritis	0.000143	0.00188	CcSEcCtD
Dihydroergotamine—Insomnia—Dexamethasone—psoriatic arthritis	0.000143	0.00188	CcSEcCtD
Dihydroergotamine—Insomnia—Betamethasone—psoriatic arthritis	0.000143	0.00188	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000142	0.00187	CcSEcCtD
Dihydroergotamine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000142	0.00187	CcSEcCtD
Dihydroergotamine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000142	0.00187	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisone—psoriatic arthritis	0.000142	0.00186	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00014	0.00183	CcSEcCtD
Dihydroergotamine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000139	0.00183	CcSEcCtD
Dihydroergotamine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000139	0.00183	CcSEcCtD
Dihydroergotamine—Urticaria—Triamcinolone—psoriatic arthritis	0.000139	0.00182	CcSEcCtD
Dihydroergotamine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000138	0.00181	CcSEcCtD
Dihydroergotamine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000138	0.00181	CcSEcCtD
Dihydroergotamine—Oedema—Prednisone—psoriatic arthritis	0.000138	0.00181	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000138	0.00181	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000138	0.00181	CcSEcCtD
Dihydroergotamine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000138	0.00181	CcSEcCtD
Dihydroergotamine—Fatigue—Betamethasone—psoriatic arthritis	0.000136	0.00179	CcSEcCtD
Dihydroergotamine—Fatigue—Dexamethasone—psoriatic arthritis	0.000136	0.00179	CcSEcCtD
Dihydroergotamine—Shock—Prednisone—psoriatic arthritis	0.000136	0.00178	CcSEcCtD
Dihydroergotamine—Pain—Dexamethasone—psoriatic arthritis	0.000135	0.00178	CcSEcCtD
Dihydroergotamine—Pain—Betamethasone—psoriatic arthritis	0.000135	0.00178	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisone—psoriatic arthritis	0.000135	0.00177	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000133	0.00175	CcSEcCtD
Dihydroergotamine—Anorexia—Prednisone—psoriatic arthritis	0.000131	0.00172	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000131	0.00172	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00013	0.00171	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00013	0.00171	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000129	0.0017	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000129	0.0017	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000129	0.00169	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000128	0.00168	CcSEcCtD
Dihydroergotamine—Malaise—Methotrexate—psoriatic arthritis	0.000127	0.00167	CcSEcCtD
Dihydroergotamine—Vertigo—Methotrexate—psoriatic arthritis	0.000127	0.00166	CcSEcCtD
Dihydroergotamine—Urticaria—Betamethasone—psoriatic arthritis	0.000126	0.00165	CcSEcCtD
Dihydroergotamine—Urticaria—Dexamethasone—psoriatic arthritis	0.000126	0.00165	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000126	0.00165	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisolone—psoriatic arthritis	0.000125	0.00165	CcSEcCtD
Dihydroergotamine—Asthenia—Triamcinolone—psoriatic arthritis	0.000125	0.00164	CcSEcCtD
Dihydroergotamine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000125	0.00164	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000125	0.00164	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000125	0.00164	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000125	0.00164	CcSEcCtD
Dihydroergotamine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000125	0.00164	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisone—psoriatic arthritis	0.000125	0.00164	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisone—psoriatic arthritis	0.000124	0.00162	CcSEcCtD
Dihydroergotamine—Pruritus—Triamcinolone—psoriatic arthritis	0.000123	0.00162	CcSEcCtD
Dihydroergotamine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000123	0.00162	CcSEcCtD
Dihydroergotamine—Dyspepsia—Prednisone—psoriatic arthritis	0.000121	0.00159	CcSEcCtD
Dihydroergotamine—Myalgia—Methotrexate—psoriatic arthritis	0.00012	0.00158	CcSEcCtD
Dihydroergotamine—Arthralgia—Methotrexate—psoriatic arthritis	0.00012	0.00158	CcSEcCtD
Dihydroergotamine—Decreased appetite—Prednisone—psoriatic arthritis	0.00012	0.00157	CcSEcCtD
Dihydroergotamine—Rash—Prednisolone—psoriatic arthritis	0.00012	0.00157	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisolone—psoriatic arthritis	0.00012	0.00157	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000119	0.00156	CcSEcCtD
Dihydroergotamine—Fatigue—Prednisone—psoriatic arthritis	0.000119	0.00156	CcSEcCtD
Dihydroergotamine—Headache—Prednisolone—psoriatic arthritis	0.000119	0.00156	CcSEcCtD
Dihydroergotamine—Discomfort—Methotrexate—psoriatic arthritis	0.000119	0.00156	CcSEcCtD
Dihydroergotamine—Confusional state—Methotrexate—psoriatic arthritis	0.000116	0.00152	CcSEcCtD
Dihydroergotamine—Dizziness—Triamcinolone—psoriatic arthritis	0.000115	0.00151	CcSEcCtD
Dihydroergotamine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000115	0.00151	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000114	0.00149	CcSEcCtD
Dihydroergotamine—Asthenia—Betamethasone—psoriatic arthritis	0.000114	0.00149	CcSEcCtD
Dihydroergotamine—Asthenia—Dexamethasone—psoriatic arthritis	0.000114	0.00149	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000113	0.00148	CcSEcCtD
Dihydroergotamine—Nausea—Prednisolone—psoriatic arthritis	0.000113	0.00148	CcSEcCtD
Dihydroergotamine—Pruritus—Betamethasone—psoriatic arthritis	0.000112	0.00147	CcSEcCtD
Dihydroergotamine—Pruritus—Dexamethasone—psoriatic arthritis	0.000112	0.00147	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000111	0.00146	CcSEcCtD
Dihydroergotamine—Vomiting—Triamcinolone—psoriatic arthritis	0.000111	0.00146	CcSEcCtD
Dihydroergotamine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000111	0.00145	CcSEcCtD
Dihydroergotamine—Rash—Triamcinolone—psoriatic arthritis	0.00011	0.00144	CcSEcCtD
Dihydroergotamine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00011	0.00144	CcSEcCtD
Dihydroergotamine—Anorexia—Methotrexate—psoriatic arthritis	0.00011	0.00144	CcSEcCtD
Dihydroergotamine—Rash—Methylprednisolone—psoriatic arthritis	0.00011	0.00144	CcSEcCtD
Dihydroergotamine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00011	0.00144	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisone—psoriatic arthritis	0.00011	0.00144	CcSEcCtD
Dihydroergotamine—Headache—Triamcinolone—psoriatic arthritis	0.000109	0.00143	CcSEcCtD
Dihydroergotamine—Headache—Methylprednisolone—psoriatic arthritis	0.000109	0.00143	CcSEcCtD
Dihydroergotamine—Body temperature increased—Prednisone—psoriatic arthritis	0.000109	0.00143	CcSEcCtD
Dihydroergotamine—Abdominal pain—Prednisone—psoriatic arthritis	0.000109	0.00143	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000108	0.00142	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000108	0.00142	CcSEcCtD
Dihydroergotamine—Hypotension—Methotrexate—psoriatic arthritis	0.000108	0.00141	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000105	0.00138	CcSEcCtD
Dihydroergotamine—Dizziness—Dexamethasone—psoriatic arthritis	0.000105	0.00137	CcSEcCtD
Dihydroergotamine—Dizziness—Betamethasone—psoriatic arthritis	0.000105	0.00137	CcSEcCtD
Dihydroergotamine—Insomnia—Methotrexate—psoriatic arthritis	0.000104	0.00137	CcSEcCtD
Dihydroergotamine—Nausea—Triamcinolone—psoriatic arthritis	0.000104	0.00136	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000103	0.00136	CcSEcCtD
Dihydroergotamine—Nausea—Methylprednisolone—psoriatic arthritis	0.000103	0.00136	CcSEcCtD
Dihydroergotamine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000103	0.00135	CcSEcCtD
Dihydroergotamine—Somnolence—Methotrexate—psoriatic arthritis	0.000102	0.00134	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000102	0.00133	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000101	0.00133	CcSEcCtD
Dihydroergotamine—Vomiting—Betamethasone—psoriatic arthritis	0.000101	0.00132	CcSEcCtD
Dihydroergotamine—Vomiting—Dexamethasone—psoriatic arthritis	0.000101	0.00132	CcSEcCtD
Dihydroergotamine—Decreased appetite—Methotrexate—psoriatic arthritis	0.0001	0.00131	CcSEcCtD
Dihydroergotamine—Rash—Dexamethasone—psoriatic arthritis	9.98e-05	0.00131	CcSEcCtD
Dihydroergotamine—Rash—Betamethasone—psoriatic arthritis	9.98e-05	0.00131	CcSEcCtD
Dihydroergotamine—Dermatitis—Dexamethasone—psoriatic arthritis	9.97e-05	0.00131	CcSEcCtD
Dihydroergotamine—Dermatitis—Betamethasone—psoriatic arthritis	9.97e-05	0.00131	CcSEcCtD
Dihydroergotamine—Fatigue—Methotrexate—psoriatic arthritis	9.93e-05	0.0013	CcSEcCtD
Dihydroergotamine—Headache—Dexamethasone—psoriatic arthritis	9.92e-05	0.0013	CcSEcCtD
Dihydroergotamine—Headache—Betamethasone—psoriatic arthritis	9.92e-05	0.0013	CcSEcCtD
Dihydroergotamine—Asthenia—Prednisone—psoriatic arthritis	9.89e-05	0.0013	CcSEcCtD
Dihydroergotamine—Pain—Methotrexate—psoriatic arthritis	9.85e-05	0.00129	CcSEcCtD
Dihydroergotamine—Pruritus—Prednisone—psoriatic arthritis	9.75e-05	0.00128	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methotrexate—psoriatic arthritis	9.49e-05	0.00125	CcSEcCtD
Dihydroergotamine—Diarrhoea—Prednisone—psoriatic arthritis	9.43e-05	0.00124	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	9.42e-05	0.00124	CcSEcCtD
Dihydroergotamine—Nausea—Dexamethasone—psoriatic arthritis	9.4e-05	0.00123	CcSEcCtD
Dihydroergotamine—Nausea—Betamethasone—psoriatic arthritis	9.4e-05	0.00123	CcSEcCtD
Dihydroergotamine—Urticaria—Methotrexate—psoriatic arthritis	9.15e-05	0.0012	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisone—psoriatic arthritis	9.12e-05	0.0012	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methotrexate—psoriatic arthritis	9.11e-05	0.0012	CcSEcCtD
Dihydroergotamine—Body temperature increased—Methotrexate—psoriatic arthritis	9.11e-05	0.0012	CcSEcCtD
Dihydroergotamine—Vomiting—Prednisone—psoriatic arthritis	8.77e-05	0.00115	CcSEcCtD
Dihydroergotamine—Rash—Prednisone—psoriatic arthritis	8.69e-05	0.00114	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisone—psoriatic arthritis	8.68e-05	0.00114	CcSEcCtD
Dihydroergotamine—Headache—Prednisone—psoriatic arthritis	8.64e-05	0.00113	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methotrexate—psoriatic arthritis	8.49e-05	0.00111	CcSEcCtD
Dihydroergotamine—Asthenia—Methotrexate—psoriatic arthritis	8.27e-05	0.00108	CcSEcCtD
Dihydroergotamine—Nausea—Prednisone—psoriatic arthritis	8.19e-05	0.00107	CcSEcCtD
Dihydroergotamine—Pruritus—Methotrexate—psoriatic arthritis	8.15e-05	0.00107	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methotrexate—psoriatic arthritis	7.88e-05	0.00103	CcSEcCtD
Dihydroergotamine—Dizziness—Methotrexate—psoriatic arthritis	7.62e-05	0.001	CcSEcCtD
Dihydroergotamine—Vomiting—Methotrexate—psoriatic arthritis	7.33e-05	0.000961	CcSEcCtD
Dihydroergotamine—Rash—Methotrexate—psoriatic arthritis	7.26e-05	0.000953	CcSEcCtD
Dihydroergotamine—Dermatitis—Methotrexate—psoriatic arthritis	7.26e-05	0.000952	CcSEcCtD
Dihydroergotamine—Headache—Methotrexate—psoriatic arthritis	7.22e-05	0.000947	CcSEcCtD
Dihydroergotamine—Nausea—Methotrexate—psoriatic arthritis	6.84e-05	0.000898	CcSEcCtD
